HomeCompareTRXDW vs PLD

TRXDW vs PLD: Dividend Comparison 2026

TRXDW yields 1333.33% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TRXDW wins by $241528694.70M in total portfolio value
10 years
TRXDW
TRXDW
● Live price
1333.33%
Share price
$0.15
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$241528700.61M
Annual income
$210,475,860,072,406.56
Full TRXDW calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — TRXDW vs PLD

📍 TRXDW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTRXDWPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TRXDW + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TRXDW pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TRXDW
Annual income on $10K today (after 15% tax)
$113,333.33/yr
After 10yr DRIP, annual income (after tax)
$178,904,481,061,545.56/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, TRXDW beats the other by $178,904,477,023,429.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TRXDW + PLD for your $10,000?

TRXDW: 50%PLD: 50%
100% PLD50/50100% TRXDW
Portfolio after 10yr
$120764353.26M
Annual income
$105,237,932,411,565.88/yr
Blended yield
87.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

TRXDW
Analyst Ratings
2
Buy
4
Hold
Consensus: Hold
Altman Z
-42.6
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TRXDW buys
0
PLD buys
0
No recent congressional trades found for TRXDW or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTRXDWPLD
Forward yield1333.33%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$241528700.61M$5.91M
Annual income after 10y$210,475,860,072,406.56$4,750,725.19
Total dividends collected$239239876.27M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy

Year-by-year: TRXDW vs PLD ($10,000, DRIP)

YearTRXDW PortfolioTRXDW Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$144,033$133,333.33$11,241$540.96+$132.8KTRXDW
2$1,948,924$1,794,807.89$13,019$991.13+$1.94MTRXDW
3$24,782,219$22,696,870.86$15,801$1,870.97+$24.77MTRXDW
4$296,245,945$269,728,970.81$20,609$3,701.21+$296.23MTRXDW
5$3,330,378,004$3,013,394,842.54$29,919$7,867.97+$3330.35MTRXDW
6$35,223,684,321$31,660,179,856.69$50,631$18,617.74+$35223.63MTRXDW
7$350,636,384,108$312,947,041,885.16$105,528$51,352.20+$350636.28MTRXDW
8$3,286,630,500,315$2,911,449,569,318.85$287,364$174,449.42+$3286630.21MTRXDW
9$29,021,346,295,663$25,504,651,660,325.88$1,081,760$774,280.77+$29021345.21MTRXDW
10$241,528,700,608,766$210,475,860,072,406.56$5,908,209$4,750,725.19+$241528694.70MTRXDW

TRXDW vs PLD: Complete Analysis 2026

TRXDWStock

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.

Full TRXDW Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this TRXDW vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TRXDW vs SCHDTRXDW vs JEPITRXDW vs OTRXDW vs KOTRXDW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.